https://www.selleckchem.com/pr....oducts/guanosine.htm
7% (95% CI 39.7%, 69.0%) for CBOP/BEP and 38.7% (95% CI 24.7%, 52.4%) for BEP (hazard ratio [HR] 0.59 (0.33, 1.06), p = 0.079). Three-year OS is 65.0% (48.8%, 77.2%) and 58.5% (43.0%, 71.2%), respectively (HR 0.79 (0.41, 1.52), p = 0.49). Twelve-month toxicity was affected by subsequent treatments, with no clear differences between arms. Stabilising chemotherapy was associated with poorer PFS (HR 2.09 (1.14, 3.81), p = 0.017), whereas unfavourable marker decline, in 60 (70%) patients, was not. CONCLUSION Although not powered for PFS,
Like
Comment
Share
